Ekso Bionics Europe GmbH
EksoGT™ is the first exoskeleton cleared by the U.S. FDA and received a CE Mark in Europe for use with stroke and spinal cord injuries from L5 to C7. The EksoGT with SmartAssist™ software is the only exoskeleton available for rehabilitation institutions that can provide adaptive amounts of power to either side of the patient`s body, challenging the patient as they progress through their continuum of care. The suit`s patented technology provides the ability to mobilize patients earlier, more frequently and with a greater number of high intensity steps. Ekso Bionics is looking for UK Distributors. Please contact us to discuss opportunities.
+49(0)40 800 40 49 0